The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-chlorophenylsulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea ID: ALA4871017
PubChem CID: 135222553
Max Phase: Preclinical
Molecular Formula: C19H16ClN3O3S
Molecular Weight: 401.88
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)c2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C19H16ClN3O3S/c20-15-1-5-17(6-2-15)27(25,26)18-7-3-16(4-8-18)23-19(24)22-13-14-9-11-21-12-10-14/h1-12H,13H2,(H2,22,23,24)
Standard InChI Key: LRFUAJAYJSNHRR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
41.7717 -13.0503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.1844 -13.7602 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
42.5928 -13.0478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5350 -15.4157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2412 -15.0044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9504 -15.4104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6566 -14.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3658 -15.4050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.0720 -14.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6535 -14.1819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.7773 -15.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4829 -14.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4803 -14.1728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7661 -13.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0633 -14.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8271 -15.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1214 -15.4170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1240 -16.2350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8382 -16.6408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5410 -16.2279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8902 -14.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8864 -14.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5914 -15.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2991 -14.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2974 -14.1672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5919 -13.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0068 -15.3954 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
7 10 2 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
13 2 1 0
4 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 4 1 0
2 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 401.88Molecular Weight (Monoisotopic): 401.0601AlogP: 3.89#Rotatable Bonds: 5Polar Surface Area: 88.16Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.68CX Basic pKa: 5.02CX LogP: 3.17CX LogD: 3.17Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -1.78
References 1. Pinkerton AB, Sessions EH, Hershberger P, Maloney PR, Peddibhotla S, Hopf M, Sergienko E, Ma CT, Smith LH, Jackson MR, Tanaka J, Tsuji T, Akiu M, Cohen SE, Nakamura T, Gardell SJ.. (2021) Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators., 41 [PMID:33798699 ] [10.1016/j.bmcl.2021.128007 ]